US regulators lift in-person restrictions on abortion pill
Officials said Thursday that a scientific review supported broadening access and allowing more pharmacies - including mail-order services- to distribute the medication.
Share:
More Stories
1:54
Boar’s Head deli meat recalled for potential listeria contamination
1h ago1:49
Bridgeport church reported finding hundreds of hypodermic needles on parish property this week
1h ago1:37
Storm Watch Team Meteorologist Skyler Harman strikes down lightning myths
4h ago1:34
Sunny this weekend, chance of storms next week
6h ago0:26
Boat Camp introduces kids to the beauty of Long Island Sound
6h ago2:13
‘You know who I am?’ Police video shows Bridgeport councilman’s ‘combative’ traffic stop
6h ago1:54
Boar’s Head deli meat recalled for potential listeria contamination
1h ago1:49
Bridgeport church reported finding hundreds of hypodermic needles on parish property this week
1h ago1:37
Storm Watch Team Meteorologist Skyler Harman strikes down lightning myths
4h ago1:34
Sunny this weekend, chance of storms next week
6h ago0:26
Boat Camp introduces kids to the beauty of Long Island Sound
6h ago2:13
‘You know who I am?’ Police video shows Bridgeport councilman’s ‘combative’ traffic stop
6h agoThe Food and Drug Administration is loosening some restrictions on where women can obtain abortion pills, including a long-standing requirement that the medication be picked up in person.
Officials said Thursday that a scientific review supported broadening access and allowing more pharmacies - including mail-order services- to distribute the medication.
But prescribing will still be limited to doctors who complete special certification. Additionally, the agency said dispensing pharmacies will have to be registered with the agency.
The decision is the latest shift in the polarized legal battle over medication abortion, which has only intensified amid the disruptions of the COVID-19 pandemic.
It is certain to spur legal challenges and restrictions in Republican-led states amid the ongoing battle over abortion.
Earlier this the year the FDA stopped enforcing the in-person dispending requirement because of the pandemic. Under Thursday’s decision, the agency will permanently drop the rule, which has long been opposed by medical societies and pro-abortion groups.
